AI assistant
INSMED Inc — Director's Dealing 2025
May 15, 2025
30150_dirs_2025-05-15_4c23a48f-01d0-4fab-a866-1d8658cca9b0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2025-05-13
Reporting Person: Lewis William (Director, Chair and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-13 | Common Stock | S | 9743 | $66.40 | Disposed | 324443 | Direct |
| 2025-05-13 | Common Stock | S | 7699 | $67.70 | Disposed | 316744 | Direct |
| 2025-05-14 | Common Stock | S | 3771 | $65.61 | Disposed | 312973 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 233924 | Indirect |
| Common Stock | 50500 | Indirect |
Footnotes
F1: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
F2: This is the weighted average sales price representing 9,743 shares sold at prices ranging from $66.02 to $67.00 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3: This is the weighted average sales price representing 7,699 shares sold at prices ranging from $67.11 to $67.81 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.